US EditionTucker Carlson and Chris Moritz Dissect the Business Side of 'Trans, Inc'
- The sex reassignment surgery market in the United States is valued at $7.5 billion, with Cedars-Sinai Hospital Health System leading the market.
- The growth of the transgender treatment industry is attributed in part to the influence of leftist groups like Human Rights Campaign and the impact of Obamacare.
- Despite claims that transgenderism has a genetic basis, there is no scientific evidence to support this argument.
Insights by Ground AI
Does this summary seem wrong?
2 Articles
2 Articles
Guess What Happened After Tucker Carlson Exposed ‘Trans, Inc’ on Twitter
Independent journalist Tucker Carlson took a deep dive into how genital mutilation and chemical castration became a lucrative industry. During the October 4th edition of his show, Carlson brought on “investment banker and policy guy” Chris Moritz to discuss who benefits from something as “unnatural and prima-facie demented” as transgenderism. Moritz discussed how companies such as Pfizer profit off of puberty blockers, testosterone and estrogen…
·Washington, United States
Read Full ArticleCoverage Details
Total News Sources2
Leaning Left0Leaning Right2Center0Last UpdatedBias Distribution100% Right
Bias Distribution
- 100% of the sources lean Right
100% Right
R 100%
Factuality
To view factuality data please Upgrade to Premium
